Mesa Laboratories (MLAB) Non-Current Deferred Tax Liability (2011 - 2025)

Mesa Laboratories has disclosed Non-Current Deferred Tax Liability across 15 years of filings, most recently posting $21.8 million for Q4 2025.

• Non-Current Deferred Tax Liability for Q4 2025 came in at $21.8 million, up 8.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.8 million (up 8.18% YoY), and the FY2025 annual result was $20.2 million, up 2.03% from the prior year.
• Non-Current Deferred Tax Liability came in at $21.8 million for Q4 2025 at Mesa Laboratories, up from $21.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $44.3 million in Q4 2023 to a low of $10.8 million in Q2 2021.
• The 5-year median for Non-Current Deferred Tax Liability is $21.7 million (2025), against an average of $27.0 million.
• Across the five-year window, Non-Current Deferred Tax Liability sank 65.37% in 2021 and surged 245.14% in 2022, its largest moves.
• Mesa Laboratories' Non-Current Deferred Tax Liability stood at $41.1 million in 2021, then slipped by 10.18% to $36.9 million in 2022, then climbed by 20.01% to $44.3 million in 2023, then sank by 54.49% to $20.2 million in 2024, then gained by 8.18% to $21.8 million in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $21.8 million (Q4 2025), $21.7 million (Q3 2025), and $21.6 million (Q2 2025), per Business Quant data.